Get started
Author

Nicola S. Cosgrove

Observed names: Cosgrove, Nicola, N Cosgrove, N. Cosgrove, Nicola Cosgrove, Nicola S Cosgrove
ORCID: 0000-0002-8296-115X
Observed ORCID: 0000-0002-8296-115X
OpenAlex ID: A5028037374
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets
2018 · Damir Varešlija, Nolan Priedigkeit, et al. · JNCI Journal of the National Cancer Institute · 124
PDF
The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export
2017 · Jekaterina Vohhodina, Eliana M. Barros, et al. · Nucleic Acids Research · 106
PDF
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
2022 · Nicola Cosgrove, Damir Varešlija, et al. · Nature Communications · 91
PDF
From Visual Exploration to Storytelling and Back Again
2016 · Samuel Gratzl, Alexander Lex, et al. · Computer Graphics Forum · 86
PDF
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
2018 · Alacoque L. Browne, Sara Charmsaz, et al. · Oncogene · 40
PDF
A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
2022 · Lucía Zhu, Diana Retana, et al. · EMBO Molecular Medicine · 38
PDF
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
2021 · Damir Varešlija, Elspeth Ward, et al. · Oncogene · 28
PDF
Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease
2024 · Gavin P. Dowling, Stephen Keelan, et al. · Breast Cancer Research and Treatment · 25
PDF
Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
2018 · Elspeth Ward, Damir Varešlija, et al. · Clinical Cancer Research · 24
ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
2020 · Sara Charmsaz, Ben Doherty, et al. · BMC Medicine · 17
PDF
An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer
2022 · Preeti Borde, Nicola Cosgrove, et al. · Cancer Gene Therapy · 15
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版 · 11
PDF
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer
2025 · Daniela Ottaviani, Mihaela Ola, et al. · JNCI Journal of the National Cancer Institute · 6
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
2023 · Nicola Cosgrove, Alex J. Eustace, et al. · npj Breast Cancer · 5
PDF
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma
2024 · Lyndsey Flanagan, Aisling Coughlan, et al. · Haematologica · 3
PDF
Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples
2025 · Nicola Cosgrove, Orla M. Fitzpatrick, et al. · Frontiers in Oncology · 2
PDF
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer
2022 · Preeti Borde, Nicola Cosgrove, et al. · Cancer Gene Therapy · 1
PDF
Abstract 5968: FOXM1 as a key regulator of metastatic outgrowth in brain metastasis of breast cancer
2026 · Shannon Cartay Kalsi, Lara Luzietti, et al. · Cancer Research
Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma
2026 · Lauren McAuley, Orla Fitzpatrick, et al. · Frontiers in Oncology
PDF
Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
2025 · Sara Charmsaz, Ben Doherty, et al. · BMC Medicine
PDF
21P Implications of KMT2C knockdown for DNA damage repair in breast cancer
2023 · P. Bredin, S. Toomey, et al. · Annals of Oncology
PDF
Cover Image, Volume 43, Issue 5
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版
PDF
Supplementary Methods from Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
2023 · Elspeth Ward, Damir Varešlija, et al.
Supplementary Figures from Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
2023 · Elspeth Ward, Damir Varešlija, et al.
Supplementary Tables from Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
2023 · Elspeth Ward, Damir Varešlija, et al.
Works count: 52
Citation count: 622
H-index: 11
I10-index: 12
Year
Topic
Type